Quoin pharmaceuticals, ltd.QNRX.US Overview

US StockHealthcare

(No presentation for QNRX)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

QNRX Overall Performance

QNRX AI Analysis & Strategy

QNRX Recent Performance

6.92%

Quoin pharmaceuticals, ltd.

0.81%

Avg of Sector

-1.14%

S&P500

QNRX PowerScanner

QNRX Key Information

QNRX Valuation Metrics

QNRX Earnings Table

QNRX Profile

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.